Login / Signup

Editors' Note: Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial Populations.

James E SieglerSteven L Galetta
Published in: Neurology (2024)
Keyphrases
  • multiple sclerosis
  • clinical trial
  • risk factors
  • phase ii
  • white matter
  • open label
  • study protocol
  • double blind
  • phase iii